Impacto de un programa de vigilancia activa y medidas de control de infecciones sobre la incidencia de bacilos gram negativos resistentes a carbapenems en una unidad de cuidados intensivos

Andrade, 2018, Virulence genes, capsular and plasmid types of multidrug-resistant CTX-M(-2 -8, -15) and KPC-2-producing Klebsiella pneumoniae isolates from four major hospitals in Brazil, Diagn Microbiol Infect Dis., 91, 164, 10.1016/j.diagmicrobio.2018.01.007 Argente, 2019, Molecular characterization of OXA-48 carbapenemase-producing Klebsiella pneumoniae strains after a carbapenem resistance increase in Catalonia, Enferm Infecc Microbiol Clin., 37, 82, 10.1016/j.eimc.2018.02.003 Candan, 2015, Klebsiella pneumoniae: Characteristics of Carbapenem Resistance and Virulence Factors, Acta Biochim. Pol., 62, 867, 10.18388/abp.2015_1148 Cantón, 2012, Global antimicrobial resistance: from surveillance to stewardship. Part 1: Surveillance and risk factors for resistance, Expert Rev Anti Infect Ther., 10, 1269, 10.1586/eri.12.120 Carmeli, 2010, Controlling the spread of carbapenemase-producing Gram-negatives: Therapeutic approach and infection control, Clin Microbiol Infect., 16, 102, 10.1111/j.1469-0691.2009.03115.x Cejas, 2019, Changing epidemiology of KPC-producing Klebsiella pneumoniae in Argentina: Emergence of hypermucoviscous ST25 and high-risk clone ST307, J Glob Antimicrob Resist., 18, 238, 10.1016/j.jgar.2019.06.005 2020, Performance Standards for Antimicrobial Susceptibility Testing: Twenty-Four Informational Supplement, CLSI Document M100-30, CLSI, Wayne Enfield, 2014, Infect Control Hosp Epidemiol, 35, 810, 10.1086/676857 Espinal, 2012, Rapid and accurate identification of genomic species from the Acinetobacter baumannii (Ab) group by MALDI-TOF MS, Clin Microbiol Infect., 18, 1097, 10.1111/j.1469-0691.2011.03696.x Gasink, 2009, Risk factors and clinical impact of Klebsiella pneumoniae carbapenemase producing K. pneumoniae, Infect Control Hosp Epidemiol, 30, 1180, 10.1086/648451 Guh, 2014, Epidemiology and prevention of carbapenem resistant Enterobacteriaceae in the United States, Expert Rev Anti Infect Ther, 12, 565, 10.1586/14787210.2014.902306 Gupta, 2011, Carbapenem-resistant Enterobacteriaceae: Epidemiology and prevention, Clin Infect Dis, 53, 60, 10.1093/cid/cir202 Hayden, 2015, Prevention of colonization and infection by Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae in long-term acute-care hospitals, Clin Infect Dis., 10.1093/cid/ciu1173 Judd, 2016, Clinical and economic impact of meropenem resistance in Pseudomonas aeruginosa infected patients, Am J Infect Control, 10.1016/j.ajic.2016.04.218 Jure, 2019, Novel patterns in the molecular epidemiology of KPC-producing Klebsiella pneumoniae in Tucumán, Argentina, J Glob Antimicrob Resist, 19, 183, 10.1016/j.jgar.2019.02.015 Karampatakis, 2018, Impact of active surveillance and infection control measures on carbapenem-resistant Gram-negative bacterial colonization and infections in intensive care, J Hosp Infect., 10.1016/j.jhin.2018.05.010 Knoester, 2014, An integrated approach to control a prolonged outbreak of multidrug-resistant Pseudomonas aeruginosa in an intensive care unit, Clin Microbiol Infect, 20, O207, 10.1111/1469-0691.12372 Landman, 2012, Transmission of carbapenem-resistant pathogens in New York City hospitals: Progress and frustration, J Antimicrob Chemother., 67, 1427, 10.1093/jac/dks063 Lin, 2013, The importance of long-term acute care hospitals in the regional epidemiology of Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae, Clin Infect Dis, 57, 1246, 10.1093/cid/cit500 Lledo, 2009, Guidance for control of infections with carbapenem-resistant or carbapenemase-producing enterobacteriaceae in acute care facilities, MMWR Morb Mortal Wkly Rep, 58, 256 Magiorakos, 2013, The rise of carbapenem resistance in Europe: Just the tip of the iceberg?, Antimicrob Resist Infect Control, 2, 6, 10.1186/2047-2994-2-6 Martin, 2016, Molecular epidemiology of colonizing and infecting isolates of Klebsiella pneumoniae, mSphere, 1, e00261, 10.1128/mSphere.00261-16 Miriagou, 2010, Acquired carbapenemases in Gram-negative bacterial pathogens: Detection and surveillance issues, Clin Microbiol Infect., 16, 112, 10.1111/j.1469-0691.2009.03116.x Monstein, 2007, Multiplex PCR amplification assay for the detection of blaSHV, blaTEM and blaCTX-M genes in Enterobacteriaceae, APMIS, 115, 1400, 10.1111/j.1600-0463.2007.00722.x Rodríguez, 2018, Epidemiología molecular de aislados de Acinetobacter baumannii resistentes a carbapenems en Argentina, Revista Argentina de Microbiología. Rodríguez-Baño, 2011, Programas de optimización de uso de antimicrobianos (PROA) en hospitales españoles: documento de consenso GEIH-SEIMC SEFH y SEMPSPH, Enferm Infecc Microbiol Clin., 30 Santolin, 2017, Colonización rectal por bacilos gram negativos multirresistentes: importancia de la detección precoz durante la hospitalización, Acta Bioquímica Clínica Latinoamericana, 51, 675 Schwaber, 2008, Predictors of carbapenem-resistant Klebsiella pneumoniae acquisition among hospitalized adults and effect of acquisition on mortality, Antimicrob Agents Chemother, 52, 1028, 10.1128/AAC.01020-07 Tenover, 1995, Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: Criteria for bacterial strain typing, J. Clin. Microbiol., 33, 2233, 10.1128/jcm.33.9.2233-2239.1995 Thatrimontrichai, 2020, Active surveillance culture program in asymptomatic patients as a strategy to control multidrug-resistant gram-negative organisms: What should be considered?, J Formos Med Assoc., 119, 1581, 10.1016/j.jfma.2019.08.015 Thomas, 2013, Early (2008-2010) hospital outbreak of Klebsiella pneumoniae producing OXA-48 carbapenemase in the UK, Int J Antimicrob Agents., 42, 531, 10.1016/j.ijantimicag.2013.08.020 Vargas, 2019, Virulence factors and clinical patterns of multiple-clone hypermucoviscous KPC-2 producing K. pneumoniae, Heliyon, 5, e01829, 10.1016/j.heliyon.2019.e01829 Viale, 2015, Impact of a hospital-wide multifaceted programme for reducing carbapenem resistant Enterobacteriaceae infections in a large teaching hospital in northern Italy, Clin Microbiol Infect, 21, 242, 10.1016/j.cmi.2014.10.020 Wernli, 2011, A call for action: The application of the international health regulations to the global threat of antimicrobial resistance, PLoS Med., 8, e1001022, 10.1371/journal.pmed.1001022 2017, Global priority list of antibiotic-resistant bacteria to guide research, discovery, and development of new antibiotics, World Health Organization